Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022
The impact of NACT on the subsequent surgical management is substantial and continues to evolve over time, resulting in less-extensive surgery. Even among high-volume Centers NACT implementation rate is still highly variable. Although we registered a significant increase in its use during the study period, these results need to be further improved.
Authors
- Federico Frusone (ORCID: https://orcid.org/0000-0001-8947-3928)
- Antonio Ponti (ORCID: https://orcid.org/0000-0002-0906-6431)
- F. Puglisi
- Maria Ida Amabile (ORCID: https://orcid.org/0000-0002-1294-9403)
- Sabina Di Matteo (ORCID: https://orcid.org/0000-0002-2586-7159)
- Isabella Palumbo (ORCID: https://orcid.org/0000-0002-4443-3954)
- Mario Taffurelli (ORCID: https://orcid.org/0000-0001-9474-995X)
- L. Marotti
- Caterina Marchiò (ORCID: https://orcid.org/0000-0003-2024-6131)
- Lucio Fortunato (ORCID: https://orcid.org/0000-0002-8252-5833)
- Alessandro De Luca (ORCID: https://orcid.org/0000-0003-0897-3547)
- Marcella Calabrese
- Corrado Tinterri (ORCID: https://orcid.org/0000-0002-7272-3924)
- Mariano Tomatis
- F.S. Santori
Institutions
- University of Rome Tor Vergata (IT)
- University of Udine (IT)
- University of Perugia (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Federico II University Hospital (IT)
- National Cancer Institute (UA)
- Centro di Riferimento Oncologico (IT)
- Ospedale Policlinico San Martino (IT)
- Candiolo Cancer Institute (IT)
- Piedmont Reference Center for Epidemiology and Cancer Prevention (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Turin (IT)
- Sapienza University of Rome (IT)
- University of Bologna (IT)
Publication Details
- Journal
- The Breast
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.breast.2024.103790
- Citations
- 6
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Roche Italia